Helena Raffayová

926 total citations
9 papers, 309 citations indexed

About

Helena Raffayová is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Helena Raffayová has authored 9 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 4 papers in Immunology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Helena Raffayová's work include Spondyloarthritis Studies and Treatments (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Helena Raffayová is often cited by papers focused on Spondyloarthritis Studies and Treatments (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Helena Raffayová collaborates with scholars based in Slovakia, Russia and United States. Helena Raffayová's co-authors include Shankar Srinivasan, Nathan Vastesaeger, Е. Л. Насонов, Nikolay V. Kungurov, Algirdas Venalis, А. А. Кубанова, Asta Baranauskaitė, Jozef Rovenský, Karel Pavelká and J. S. Hill Gaston and has published in prestigious journals such as Annals of the New York Academy of Sciences, Annals of the Rheumatic Diseases and PubMed.

In The Last Decade

Helena Raffayová

8 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helena Raffayová Slovakia 5 262 218 111 29 14 9 309
D Halter United States 5 302 1.2× 225 1.0× 160 1.4× 17 0.6× 5 0.4× 9 357
J Brückel United States 6 363 1.4× 175 0.8× 134 1.2× 11 0.4× 18 1.3× 9 393
I. Spiller Germany 7 427 1.6× 279 1.3× 117 1.1× 17 0.6× 26 1.9× 12 470
Anthony Turkiewicz United States 8 134 0.5× 135 0.6× 75 0.7× 21 0.7× 18 1.3× 10 208
Е. Yu. Loginova Russia 7 202 0.8× 181 0.8× 70 0.6× 8 0.3× 6 0.4× 76 239
Maria Stefania Cutro Italy 5 186 0.7× 130 0.6× 74 0.7× 8 0.3× 11 0.8× 6 215
M. Bohl-Bühler Germany 10 449 1.7× 209 1.0× 156 1.4× 7 0.2× 16 1.1× 24 485
Mau R Germany 4 333 1.3× 170 0.8× 77 0.7× 12 0.4× 19 1.4× 6 345
Sibel Bakırcı Canada 10 197 0.8× 100 0.5× 109 1.0× 35 1.2× 24 1.7× 22 244
Steffen Jugl Switzerland 13 312 1.2× 252 1.2× 159 1.4× 23 0.8× 8 0.6× 21 357

Countries citing papers authored by Helena Raffayová

Since Specialization
Citations

This map shows the geographic impact of Helena Raffayová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Raffayová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Raffayová more than expected).

Fields of papers citing papers by Helena Raffayová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Raffayová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Raffayová. The network helps show where Helena Raffayová may publish in the future.

Co-authorship network of co-authors of Helena Raffayová

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Raffayová. A scholar is included among the top collaborators of Helena Raffayová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Raffayová. Helena Raffayová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Leung, Ying Ying, Т. В. Коротаева, Liliana Candia, et al.. (2021). AB0531 THERAPIES FOR PERIPHERAL JOINT INVOLVEMENT IN PSORIATIC ARTHRITIS: A SYSTEMATIC LITERATURE REVIEW. Annals of the Rheumatic Diseases. 80. 1296–1297. 1 indexed citations
2.
Stamm, Tanja, Jozef Rovenský, Helena Raffayová, et al.. (2012). Rituximab in psoriatic arthritis: an exploratory evaluation. Annals of the Rheumatic Diseases. 71(11). 1868–1871. 41 indexed citations
3.
Sieper, Joachim, Shankar Srinivasan, Omid Zamani, et al.. (2012). Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study. Annals of the Rheumatic Diseases. 72(10). 1621–1627. 94 indexed citations
4.
Baranauskaitė, Asta, Helena Raffayová, Nikolay V. Kungurov, et al.. (2011). Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study. Annals of the Rheumatic Diseases. 71(4). 541–548. 157 indexed citations
5.
Rovenský, Jozef, Helena Raffayová, Richard Imrich, et al.. (2006). Prolactin and Growth Hormone Responses to Hypoglycemia in Patients with Systemic Sclerosis and Psoriatic Arthritis. Annals of the New York Academy of Sciences. 1069(1). 145–148.
6.
Rovenský, J, et al.. (2001). Increased demand for steroid therapy in hyperprolactinemic patients with rheumatoid arthritis.. PubMed. 23(4). 145–9. 4 indexed citations
7.
Raffayová, Helena, et al.. (2000). [Secondary hypertrophic osteoarthropathy in a patient with pulmonary carcinoma].. PubMed. 101(4). 219–22. 1 indexed citations
8.
Raffayová, Helena, et al.. (2000). Treatment with cyclosporin in patients with psoriatic arthritis: results of clinical assessment.. PubMed. 20(1-2). 1–11. 6 indexed citations
9.
Partsch, G, B.F. Leeb, M Stancíková, et al.. (1997). Low serum hyaluronan in psoriatic arthritis patients in comparison to rheumatoid arthritis patients.. PubMed. 14(4). 381–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D Halter Breakdown of academic impact, for papers by J Brückel Breakdown of academic impact, for papers by I. Spiller Breakdown of academic impact, for papers by Anthony Turkiewicz Breakdown of academic impact, for papers by Е. Yu. Loginova Breakdown of academic impact, for papers by Maria Stefania Cutro Breakdown of academic impact, for papers by M. Bohl-Bühler Breakdown of academic impact, for papers by Mau R Breakdown of academic impact, for papers by Sibel Bakırcı Breakdown of academic impact, for papers by Steffen Jugl
Rankless by CCL
2026